Related Experiment Video

Updated: Aug 26, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Epitopes recognized by CBV4 responding T cells: effect of type 1 diabetes and associated HLA-DR-DQ haplotypes

Jane Marttila1, Heikki Hyöty, Kirsti Näntö-Salonen

  • 1JDRF Center for Preevention of Type 1 Diabetes in Finland, Finland. jane.marttila@utu.fi

Virology
|February 18, 2004
PubMed

Insights

This study investigated coxsackievirus B4 (CBV4) epitopes in children with type 1 diabetes (T1D). T-cell responses to viral proteins were linked to infection history and HLA genotype, not diabetes itself.

Area of Science:

  • Immunology
  • Virology
  • Endocrinology

Background:

  • Type 1 diabetes (T1D) is a complex autoimmune disease.
  • Coxsackievirus B4 (CBV4) has been implicated as a potential environmental trigger for T1D.
  • Understanding T-cell responses to CBV4 is crucial for elucidating T1D pathogenesis.

Purpose of the Study:

  • To characterize T-cell epitopes recognized by CBV4-specific T-cell lines.
  • To investigate the influence of infection history and HLA genotype on T-cell responses.
  • To determine if diabetes-specific T-cell epitopes exist.

Main Methods:

  • Establishment of CBV4-specific T-cell lines from children with T1D and at-risk healthy children.
  • Peptide mapping to identify recognized epitopes within the CBV4 VP1 region.
  • Analysis of T-cell responsiveness correlated with infection history (neutralizing antibodies) and HLA genotypes.

Main Results:

  • T-cell responsiveness to CBV4 VP1 peptides was significantly associated with the presence of neutralizing antibodies to CBV serotypes (P = 0.01).
  • Specific HLA genotypes, notably HLA-DR4-DQB1*0302, were linked to recognition of particular VP1 peptides (P = 0.02).
  • No distinct diabetes-specific epitopes were identified; responses were largely similar between T1D and healthy children.

Conclusions:

  • T-cell recognition of CBV4 epitopes is influenced by prior viral exposure and host HLA genetics.
  • The findings do not support the existence of unique T-cell epitopes driving T1D pathogenesis specific to CBV4 infection.
  • Further research is needed to fully understand the role of viral infections in T1D development.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...